Proteomics

Dataset Information

A multi-omics analysis of glioma chemoresistance using a hybrid microphysiological model of glioblastoma


ABSTRACT: Chemoresistance is a major clinical challenge in management of glioblastoma (GBM) Temozolomide (TMZ) is the chemotherapeutic drug of choice for GBM; however, the therapeutic effect of TMZ is limited due to the development of resistance. Recapitulating GBM chemoresistance in a controlled environment is thus essential in understanding the mechanism of chemoresistance. Herein, we present a hybrid microphysiological model of chemoresistant GBM-on-a-chip (HGoC) by directly co-culturing TMZ-resistant GBM spheroids with healthy neurons to mimic the microenvironment of both the tumor and the surrounding healthy tissue. We characterized the model with proteomics, lipidomics, and secretome assays. The results showed that our artificial model recapitulated the molecular signatures of recurrent GBM in humans. Both showed alterations in vesicular transport and cholesterol pathways, mitotic quiescence, and a switch in metabolism to oxidative phosphorylation associated with a transition from mesenchymal to amoeboid. This is the first report to unravel the interplay of all these molecular changes as a mechanism of chemoresistance in glioblastoma. Moreover, we have shown that acquisition of resistance increases invasiveness and the presence of neurons decreases this property. 1. Seyfoori, A., et al., Self-filling microwell arrays (SFMAs) for tumor spheroid formation. Lab Chip, 2018. 18(22): p. 3516-3528. 2. Amereh, M., et al., In-Silico Modeling of Tumor Spheroid Formation and Growth. Micromachines (Basel), 2021. 12(7). 3. Senko, M.W., et al., Novel Parallelized Quadrupole/Linear Ion Trap/Orbitrap Tribrid Mass Spectrometer Improving Proteome Coverage and Peptide Identification Rates. Analytical Chemistry, 2013. 85(24): p. 11710-11714. 4. Zhou, G., et al., NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res, 2019. 47(W1): p. W234-w241. 5. Xia, J., E.E. Gill, and R.E. Hancock, NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc, 2015. 10(6): p. 823-44. 6. Breuer, K., et al., InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation. Nucleic Acids Res, 2013. 41(Database issue): p. D1228-33.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

DISEASE(S): Glioblastoma

SUBMITTER: Rui Vitorino  

LAB HEAD: Mohsen Akbari

PROVIDER: PXD037753 | Pride | 2025-06-09

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
2D_NR_1_1.raw Raw
2D_NR_1_3.raw Raw
2D_NR_2_1_20190702225513.raw Raw
2D_R_1_2_20190703015632.raw Raw
2D_R_2_1.raw Raw
Items per page:
1 - 5 of 13
altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets